Wird geladen...
Study partners should be required in preclinical Alzheimer’s disease trials
BACKGROUND: In an effort to intervene earlier in Alzheimer’s disease (AD), clinical trials are testing promising candidate therapies in preclinical disease. Preclinical AD trial participants are cognitively normal, functionally independent, and autonomous decision-makers. Yet, like AD dementia trial...
Gespeichert in:
| Veröffentlicht in: | Alzheimers Res Ther |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5719524/ https://ncbi.nlm.nih.gov/pubmed/29212555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0327-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|